BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 126 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $288,068 | +113.2% | 46,613 | +75.2% | 0.00% | – |
| Q1 2024 | $135,123 | +65.7% | 26,599 | +95.4% | 0.00% | – |
| Q4 2023 | $81,536 | -56.6% | 13,612 | -26.3% | 0.00% | – |
| Q1 2021 | $188,000 | +113.6% | 18,459 | +0.6% | 0.00% | – |
| Q1 2018 | $88,000 | -11.1% | 18,350 | +3.1% | 0.00% | -100.0% |
| Q2 2017 | $99,000 | +450.0% | 17,800 | +714.6% | 0.00% | – |
| Q1 2017 | $18,000 | -89.0% | 2,185 | -91.6% | 0.00% | -100.0% |
| Q4 2016 | $164,000 | +51.9% | 25,950 | +6.4% | 0.00% | 0.0% |
| Q3 2016 | $108,000 | +129.8% | 24,400 | +48.8% | 0.00% | – |
| Q2 2016 | $47,000 | +34.3% | 16,400 | +31.2% | 0.00% | – |
| Q1 2016 | $35,000 | -70.3% | 12,500 | +9.6% | 0.00% | -100.0% |
| Q4 2015 | $118,000 | +42.2% | 11,400 | +56.2% | 0.00% | 0.0% |
| Q3 2015 | $83,000 | +1085.7% | 7,300 | +812.5% | 0.00% | – |
| Q1 2015 | $7,000 | -30.0% | 800 | 0.0% | 0.00% | – |
| Q4 2014 | $10,000 | -9.1% | 800 | -27.6% | 0.00% | – |
| Q3 2014 | $11,000 | +10.0% | 1,105 | +37.3% | 0.00% | – |
| Q2 2014 | $10,000 | +11.1% | 805 | 0.0% | 0.00% | – |
| Q1 2014 | $9,000 | +50.0% | 805 | +0.6% | 0.00% | – |
| Q4 2013 | $6,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q3 2013 | $6,000 | +500.0% | 800 | 0.0% | 0.00% | – |
| Q2 2013 | $1,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $40,692,000 | 16.07% |
| Fairmount Funds Management LLC | 3,343,107 | $35,370,000 | 8.10% |
| Kynam Capital Management, LP | 936,563 | $9,909,000 | 2.53% |
| Velan Capital Investment Management LP | 225,000 | $2,381,000 | 2.42% |
| ORACLE INVESTMENT MANAGEMENT INC | 603,994 | $6,390,000 | 1.94% |
| TANG CAPITAL MANAGEMENT LLC | 1,200,000 | $12,696,000 | 1.93% |
| MPM BioImpact LLC | 639,089 | $6,762,000 | 1.88% |
| Ghost Tree Capital, LLC | 325,000 | $3,439,000 | 1.79% |
| Sarissa Capital Management LP | 1,390,790 | $14,715,000 | 1.48% |
| Prosight Management, LP | 176,680 | $1,869,000 | 1.47% |